Results
1
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
1 companies
argenx
Market Cap: €29.8b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€487.40
7D
4.6%
1Y
14.3%